RT Journal Article
SR Electronic
T1 Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.18.20099960
DO 10.1101/2020.05.18.20099960
A1 Bryce, Clare
A1 Grimes, Zachary
A1 Pujadas, Elisabet
A1 Ahuja, Sadhna
A1 Beasley, Mary Beth
A1 Albrecht, Randy
A1 Hernandez, Tahyna
A1 Stock, Aryeh
A1 Zhao, Zhen
A1 Rasheed, Mohamed Al
A1 Chen, Joyce
A1 Li, Li
A1 Wang, Diane
A1 Corben, Adriana
A1 Haines, Kenneth
A1 Westra, William
A1 Umphlett, Melissa
A1 Gordon, Ronald E.
A1 Reidy, Jason
A1 Petersen, Bruce
A1 Salem, Fadi
A1 Fiel, MariaIsabel
A1 El Jamal, Siraj M.
A1 Tsankova, Nadia M.
A1 Houldsworth, Jane
A1 Mussa, Zarmeen
A1 Liu, Wen-Chun
A1 Veremis, Brandon
A1 Sordillo, Emilia
A1 Gitman, Melissa R
A1 Nowak, Michael
A1 Brody, Rachel
A1 Harpaz, Noam
A1 Merad, Miriam
A1 Gnjatic, Sacha
A1 Donnelly, Ryan
A1 Seigler, Patricia
A1 Keys, Calvin
A1 Cameron, Jennifer
A1 Moultrie, Isaiah
A1 Washington, Kae-Lynn
A1 Treatman, Jacquelyn
A1 Sebra, Robert
A1 Jhang, Jeffrey
A1 Firpo, Adolfo
A1 Lednicky, John
A1 Paniz-Mondolfi, Alberto
A1 Cordon-Cardo, Carlos
A1 Fowkes, Mary
YR 2020
UL http://medrxiv.org/content/early/2020/05/22/2020.05.18.20099960.abstract
AB BACKGROUND Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its associated clinical syndrome COVID-19 are causing overwhelming morbidity and mortality around the globe, disproportionately affecting New York City. A comprehensive, integrative autopsy series that advances the mechanistic discussion surrounding this disease process is still lacking.METHODS Autopsies were performed at the Mount Sinai Hospital on 67 COVID-19 positive patients and data from the clinical records were obtained from the Mount Sinai Data Warehouse. The experimental design included a comprehensive microscopic examination carried out by a team of expert pathologists, along with transmission electron microscopy, immunohistochemistry, RNA in situ hybridization, as well as immunology and serology assays.RESULTS Laboratory results of our COVID-19 cohort show elevated inflammatory markers, abnormal coagulation values, and elevated cytokines IL-6, IL-8 and TNFα. Autopsies revealed large pulmonary emboli in four cases. We report microthrombi in multiple organ systems including the brain, as well as conspicuous hemophagocytosis and a secondary hemophagocytic lymphohistiocytosis-like syndrome in many of our patients. We provide electron microscopic, immunofluorescent and immunohistochemical evidence of the presence of the virus and the ACE2 receptor in our samples.CONCLUSIONS We report a comprehensive autopsy series of 67 COVID-19 positive patients revealing that this disease, so far conceptualized as a primarily respiratory viral illness, also causes endothelial dysfunction, a hypercoagulable state, and an imbalance of both the innate and adaptive immune responses. Novel findings reported here include an endothelial phenotype of ACE2 in selected organs, which correlates with clotting abnormalities and thrombotic microangiopathy, addressing the prominent coagulopathy and neuropsychiatric symptoms. Another original observation is that of macrophage activation syndrome, with hemophagocytosis and a hemophagocytic lymphohistiocytosis-like disorder, underlying the microangiopathy and excessive cytokine release. We discuss the involvement of critical regulatory pathways.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Department of Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data available are included in figures and tables. For any additional information feel free to contact the senior author.